Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PF-04518600 + Axitinib vs Axitinib in Metastatic Renal Cell Carcinoma
NCT03092856Phase 2Active, not recruiting
- Sponsor
- University of Southern California
- Start
- Jul 2017
- Primary completion
- Dec 2026
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of ivuxolimab in renal cell carcinoma (RCC), sponsored by University of Southern California. Started Jul 2017; status: active, not recruiting.
02
Drugs
ivuxolimab
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT03092856.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03092856.